Page 109 - 南京医科大学学报自然科学版
P. 109

第41卷第12期      何应丰,陈建军,周亮亮,等. 血浆长链非编码RNA MALAT1对脓毒症的诊断、严重程度以及预后的
                 2021年12月             评估价值研究[J]. 南京医科大学学报(自然科学版),2021,41(12):1811-1815                  ·1815 ·


                效性和简便性不如脓毒症的传统评估指标。但是,                                 2017,39(5):1269-1276
                血浆 MALAT1 作为基因靶点,为脓毒症的机制研究                       [12] DAI L,ZHANG G,CHENG Z,et al. Knockdown of Ln⁃
                和生物治疗开辟了新的思路,未来还需要多中心、大                                cRNA MALAT1 contributes to the suppression of inflam⁃
                样本的研究来进一步评估血浆MALAT1作为脓毒症                               matory responses by up⁃regulating miR⁃146a in LPS⁃in⁃
                                                                       duced acute lung injury[J]. Connect Tissue Res,2018,59
                生物标志物和治疗靶点的临床应用价值。
                                                                      (6):581-592
               [参考文献]                                            [13]DING Y,GUO F,ZHU T,et al. Mechanism of long non⁃
                                                                       coding RNA MALAT1 in lipopolysaccharide ⁃ induced
               [1] RHODES A,EVANS L E,ALHAZZANI W,et al. Surviv⁃
                    ing sepsis campaign:international guidelines for manage⁃  acute kidney injury is mediated by the miR⁃146a/NF⁃kap⁃
                                                                       paB signaling pathway[J]. Int J Mol Med,2018,41(1):
                    ment of sepsis and septic shock:2016[J]. Intensive Care
                    Med,2017,43(3):304-377                             446-454
               [2] FLEISCHMANN C,SCHERAG A,ADHIKARI N K,et al.   [14] PAN L,LIU D,ZHAO L,et al. Long noncoding RNA
                    Assessment of global incidence and mortality of hospital⁃  MALAT1 alleviates lipopolysaccharide⁃induced inflamma⁃
                    treated sepsis. current estimates and limitations[J]. Am J  tory injury by upregulating microRNA ⁃ 19b in murine
                    Respir Crit Care Med,2016,193(3):259-272           chondrogenic ATDC5 cells[J]. J Cell Biochem,2018,119
               [3] VAN DER POLL T,VAN D E VEERDONK F L,SCICLU⁃        (12):10165-10175
                    NA B P,et al. The immunopathology of sepsis and poten⁃  [15] GAST M,RAUCH B H,NAKAGAWA S,et al. Immune
                    tial therapeutic targets[J]. Nat Rev Immunol,2017,17  system⁃mediated atherosclerosis caused by deficiency of
                    (7):407-420                                        long non⁃coding RNA MALAT1 in ApoE⁃/⁃mice[J]. Car⁃
               [4] WANG W,YANG N,WEN R,et al. Long Noncoding           diovasc Res,2019,115(2):302-314
                    RNA:Regulatory mechanisms and therapeutic potential in  [16] ZHAO G,SU Z,SONG D,et al. The long noncoding RNA
                    sepsis[J]. Front Cell Infect Microbiol,2021,11:563126  MALAT1 regulates the lipopolysaccharide ⁃ induced in⁃
               [5] VERGADI E,VAPORIDI K,TSATSANIS C. Regulation        flammatory response through its interaction with NF⁃kap⁃
                    of endotoxin tolerance and compensatory anti⁃inflammato⁃  paB[J]. FEBS Lett,2016,590(17):2884-2895
                    ry response syndrome by non⁃coding RNAs[J]. Front Im⁃  [17] TIAN X,XU G. Clinical value of lncRNA MALAT1 as a
                    munol,2018,9:2705                                  prognostic marker in human cancer:systematic review
               [6] ZHANG B,ARUN G,MAO Y S,et al. The lncRNA            and meta⁃analysis[J]. BMJ Open,2015,5(9):e008653
                    Malat1 is dispensable for mouse development but its tran⁃  [18] WU Y,LU W,XU J,et al. Prognostic value of long non⁃
                    scription plays a cis⁃regulatory role in the adult[J]. Cell  coding RNA MALAT1 in cancer patients[J]. Tumour Bi⁃
                    Rep,2012,2(1):111-123                              ol,2016,37(1):897-903
               [7] JI P,DIEDERICHS S,WANG W,et al. MALAT⁃1,a nov⁃  [19] SHAKER O G,ABDELALEEM O O,MAHMOUD R H,et
                    el noncoding RNA,and thymosin beta4 predict metastasis  al. Diagnostic and prognostic role of serum miR⁃20b,miR⁃
                    and survival in early⁃stage non⁃small cell lung cancer[J].  17 ⁃ 3p,HOTAIR,and MALAT1 in diabetic retinopathy
                    Oncogene,2003,22(39):8031-8041                    [J]. IUBMB Life,2019,71(3):310-320
               [8] ZHANG X,HAMBLIN M H,YIN K J. The long noncod⁃  [20] SINGER M,DEUTSCHMAN C S,SEYMOUR C W,et al.
                    ing RNA Malat1:Its physiological and pathophysiological  The third international consensus definitions for sepsis
                    functions[J]. RNA Biol,2017,14(12):1705-1714       and septic shock(sepsis⁃3)[J]. JAMA,2016,315(8):
               [9] TANO K,MIZUNO R,OKADA T,et al. MALAT⁃ 1 en⁃         801-810
                    hances cell motility of lung adenocarcinoma cells by influ⁃  [21] VINCENT J L,MARTIN G S,LEVY M M. qSOFA does
                    encing the expression of motility⁃related genes[J]. FEBS  not replace SIRS in the definition of sepsis[J]. Crit Care,
                    Lett,2010,584(22):4575-4580                        2016,20(1):210
               [10] CHEN H,WANG X,YAN X,et al. LncRNA MALAT1     [22] GODINJAK A,IGLICA A,RAMA A,et al. Predictive val⁃
                    regulates sepsis ⁃ induced cardiac inflammation and dys⁃  ue of SAPS Ⅱ and APACHE Ⅱ scoring systems for pa⁃
                    function via interaction with miR⁃125b and p38 MAPK/  tient outcome in a medical intensive care unit[J]. Acta
                    NFkappaB[J]. Int Immunopharmacol,2018,55:69-76     Med Acad,2016,45(2):97-103
               [11] YU Z,RAYILE A,ZHANG X,et al. Ulinastatin protects  [23]DAHABA A A,METZLER H. Procalcitonin’s role in the
                    against lipopolysaccharide⁃induced cardiac microvascular  sepsis cascade. Is procalcitonin a sepsis marker or media⁃
                    endothelial cell dysfunction via downregulation of ln⁃  tor?[J]. Minerva Anestesiol,2009,75(7⁃8):447-452
                    cRNA MALAT1 and EZH2 in sepsis[J]. Int J Mol Med,                       [收稿日期] 2021-06-30
   104   105   106   107   108   109   110   111   112   113   114